SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2083SuperGen Announces Signing of Definitive Agreement to Acquire Montigen Pharmaceunigel bates-1/27/2006
2082Boston Scientific Faces Pivotal Test After Victory in Fight for Guidant By THOMDoc Bones-1/26/2006
2081Upheaval at Imclone (IMCL, BMS, AMGN, ABGX) [The Biotech Stock Blog weighs in. Icebrg-1/26/2006
2080Merck: Ready for a biotech buying spree Looking for firms with stable products aIcebrg-1/25/2006
2079ImClone Considering Sale; Erbitux Growth Continues [Some background from BioWorIcebrg-1/25/2006
2078Indeed, if they're cash rich, but pipeline poor, can't they inlicense sotuck-1/24/2006
2077Isn't it strange to see a (cash-rich) biotech company giving up like this? HIcebrg-1/24/2006
2076Perhaps OT, but Imclone would <i>like</i> to be munched. ImClone ontnsaf-1/24/2006
2075Big Drug Makers Take a Pass on Serono By JASON SINGER and JEANNE WHALEN Staff Doc Bones-1/24/2006
2074$600k/yr would have been a bargain: <i>Under an eight-year tenancy agreemBiomaven-1/23/2006
2073SkyePharma chairman resigns <i>Gowrie-Smith's case wasn't helped nigel bates-1/23/2006
2072<i>Skyepharma board stands on its dignity... ...leaving it looking prettynigel bates-1/20/2006
2071<i>Johnson & Johnson's technology, known as the Rapid Exchange delDewDiligence_on_SI-1/18/2006
2070Abbott Looks to Diversify By Helping Boston Scientific By LEILA ABBOUD Staff RDoc Bones-1/18/2006
2069NI: >Will spin off wine and cheese< So...what would be left? (:>)fred hayes-1/17/2006
2068Boston Scientific Raises Bid For Guidant to $80 a Share New Offer Values MedicaDoc Bones-1/17/2006
2067<i>it might be dilutive, and Pfizer could miss their earnings target.</Biomaven-1/13/2006
2066Boston Scientific Raises Guidant Bid By SYLVIA PAGAN WESTPHAL, DENNIS K. BERMANDoc Bones-1/13/2006
2065With the Spotlight on a Rival, St. Jude Medical Shines By BARNABY J. FEDER [NYT]sim1-1/13/2006
2064I've been needling Hank McKinnell in print to do something bold. So, extrapoNeuroInvestment-1/12/2006
2063I got a shock when I saw this headline in my incoming eMail. <b>Pfizer toIan@SI-1/12/2006
2062BSX ups bid for GDT: investorshub.com investorshub.comDewDiligence_on_SI-1/12/2006
2061Boston Scientific May Raise Guidant Bid After J&J (Update1) Jan. 12 (Bloombsim1-1/12/2006
2060Johnson & Johnson to acquire Guidant for 23.2 bln usd - UPDATE 01.11.2006, 1sim1-1/12/2006
2059SkyePharma PLC - Strategic Review Update Wednesday January 11, 10:23 am ET LONDnigel bates-1/11/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News